Skip to main content

Peer Review reports

From: Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic

Original Submission
24 Feb 2022 Submitted Original manuscript
12 Mar 2022 Reviewed Reviewer Report - Matthias Briel
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
12 Mar 2022 Editorially accepted
4 Apr 2022 Article published 10.1186/s13063-022-06182-3

You can find further information about peer review here.

Back to article page